Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
The Journal of General Virology|March 7, 2009
Expression and processing of human immunodeficiency virus type 1 gp160 using the vesicular stomatitis virus New Jersey serotype vector systemKunyu Wu, Gyoung Nyoun Kim, C Yong KangVirus Research|December 5, 2012
Genetically modified VSV(NJ) vector is capable of accommodating a large foreign gene insert and allows high level gene expressionHwa-Yong An, Gyoung Nyoun Kim, Kunyu Wu, et al.Sensors (Basel, Switzerland)|September 27, 2025
Trajectory-Regularized Localization in Asynchronous Acoustic Networks via Enhanced PSO OptimizationJingyi Zhou, Qiushi Zhao, Zihan Feng, et al.Journal of Virology|April 10, 2015
Creation of matrix protein gene variants of two serotypes of vesicular stomatitis virus as prime-boost vaccine vectorsGyoung Nyoun Kim, Kunyu Wu, Jiho Patrick Hong, et al.Sensors (Basel, Switzerland)|April 26, 2025
ATTRN: Acoustic Information Encoder and Temperature Field Reconstruction Decoder Network for Boiler Temperature Field ReconstructionKunyu Wu, Keqi Ni, Liwei Chen, et al.Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology|August 28, 2002
[Characterization of genome of A/Guangzhou/333/99(H9N2) virus]YuanJi Guo, Jianping Xie, Kunyu Wu, et al.Advances in Colloid and Interface Science|January 9, 2026
Oil-rock interaction controlling oil migration and accumulation in porous shale reservoir: Insights from varied lacustrine basins in ChinaSongtao Wu, Guanwen Lu, Ming Yuan, et al.The Journal of General Virology|April 29, 2021
Induction of protective immune responses against a lethal Zika virus challenge post-vaccination with a dual serotype of recombinant vesicular stomatitis virus carrying the genetically modified Zika virus E protein geneJung Ah Choi, Kunyu Wu, Gyoung Nyoun Kim, et al.Iscience|March 14, 2023
Monovalent and trivalent VSV-based COVID-19 vaccines elicit neutralizing antibodies and CD8+ T cells against SARS-CoV-2 variantsKate A Parham, Gyoung Nyoun Kim, Connor G Richer, et al.Retrovirology|November 30, 2016
First Phase I human clinical trial of a killed whole-HIV-1 vaccine: demonstration of its safety and enhancement of anti-HIV antibody responsesEunsil Choi, Chad J Michalski, Seung Ho Choo, et al.Pageof 2